Industry Research Reports

Home > Reports > Service & Software > Global Prenatal Second-Generation DNA Sequencing Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Global Prenatal Second-Generation DNA Sequencing Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Industry: Service & Software

Published Date: 2026-03-11

Pages: 106 Pages

Report ld: 6037646

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Prenatal Second-Generation DNA Sequencing Market Size(US$)

CAGR 2026-2032

10.9%

Market Size,2032

USD 1,842

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 988 million

Market Forecast in 2032(Value)

US$ 1,842 million

CAGR

10.9%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Prenatal Second-Generation DNA Sequencing market size was US$ 897 million in 2025 and is forecast to reach a readjusted size of US$ 1842 million by 2032 with a CAGR of 10.9% during the forecast period 2026-2032.

Prenatal Second-Generation DNA Sequencing refers to prenatal genetic testing that uses second-generation next-generation sequencing methods to generate DNA sequence information relevant to a pregnancy for screening or diagnostic assessment. It typically relies on high-throughput short-read sequencing and computational analysis to detect fetal genetic signals, interpret genomic variation, and produce clinically actionable results that guide follow-up testing and pregnancy management. The approach can be applied through noninvasive workflows that analyze fetal genetic material present in maternal blood as well as through sequencing of fetal or placental samples obtained via clinical procedures, with outputs delivered as structured reports designed to support medical decision making and genetic counseling.

Prenatal Second-Generation DNA Sequencing is becoming a central engine of modernization in prenatal care as health systems seek earlier, safer, and more information-rich assessment of fetal genetic risk. From a research report perspective, market momentum is driven by the scalability of high-throughput sequencing workflows, improving bioinformatics and laboratory automation, and a steady expansion of clinical use cases from core aneuploidy screening toward broader panels and, in selected high-risk pathways, more comprehensive sequencing-based diagnostics. Competitive dynamics are increasingly shaped by analytical performance in low fetal signal conditions, robustness of variant calling and classification, turnaround reliability, integration with clinician-friendly reporting and counseling pathways, and the ability to operate within tightening regulatory and reimbursement expectations. As adoption deepens, differentiation will continue to shift from basic sequencing capacity to end-to-end clinical governance and operational execution, favoring providers that can deliver consistent quality, strong interpretability, and scalable service networks across geographies.

The global Prenatal Second-Generation DNA Sequencing market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.

MARKET SEGMENTATION

By Company

Natera
Labcorp
Quest Diagnostics
MedGenome
Mayo Clinic Laboratories
GeneDx
PreventionGenetics
SYNLAB
Myriad Genetics
GGA
Fulgent Genetics
Rainbow Genomics
BillionToOne
BGI Genomics
Berry Genomics
Annaroad
Weihansi Biomedical Technology

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Targeted Panels
Exome Sequencing
Others

Segment by Application

Public Hospitals
Private Hospitals

Segment by Category

Non-Invasive
Invasive

Segment by Division

Public Health Program
Consumer
Others

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Prenatal Second-Generation DNA Sequencing value chain, addressing:

- Market entry risks/opportunities by region

- Product mix optimization based on local practices

- Competitor tactics in fragmented vs. consolidated markets

biaoTi QYRESEARCH'S STRENGTHS

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market by Type

1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032

1.2.2 Targeted Panels

1.2.3 Exome Sequencing

1.2.4 Others

1.3 Market by Application

1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032

1.3.2 Public Hospitals

1.3.3 Private Hospitals

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Prenatal Second-Generation DNA Sequencing Market Perspective (2021-2032)

2.2 Global Market Size by Region: 2021 vs 2025 vs 2032

2.3 Global Prenatal Second-Generation DNA Sequencing Market Share by Revenue, by Region (2021-2026)

2.4 Global Prenatal Second-Generation DNA Sequencing Revenue Forecast by Region (2027-2032)

2.5 Major Regions and Emerging Markets Analysis

2.5.1 North America Prenatal Second-Generation DNA Sequencing Market Size and Prospective (2021-2032)

2.5.2 Europe Prenatal Second-Generation DNA Sequencing Market Size and Prospective (2021-2032)

2.5.3 China Prenatal Second-Generation DNA Sequencing Market Size and Prospective (2021-2032)

2.5.4 Japan Prenatal Second-Generation DNA Sequencing Market Size and Prospective (2021-2032)

2.5.5 Southeast Asia Prenatal Second-Generation DNA Sequencing Market Size and Prospective (2021-2032)

2.5.6 India Prenatal Second-Generation DNA Sequencing Market Size and Prospective (2021-2032)

2.5.7 South America Prenatal Second-Generation DNA Sequencing Market Size and Prospective (2021-2032)

2.5.8 Middle East Prenatal Second-Generation DNA Sequencing Market Size and Prospective (2021-2032)

3 Breakdown Data by Type

3.1 Global Prenatal Second-Generation DNA Sequencing Historical Market Size by Type (2021-2026)

3.2 Global Prenatal Second-Generation DNA Sequencing Forecasted Market Size by Type (2027-2032)

3.3 Representative Players for Different Types of Prenatal Second-Generation DNA Sequencing

4 Breakdown Data by Application

4.1 Global Prenatal Second-Generation DNA Sequencing Historical Market Size by Application (2021-2026)

4.2 Global Prenatal Second-Generation DNA Sequencing Forecasted Market Size by Application (2027-2032)

4.3 New Sources of Growth in Prenatal Second-Generation DNA Sequencing Applications

5 Competitive Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top Prenatal Second-Generation DNA Sequencing Players by Revenue (2021-2026)

5.1.2 Global Prenatal Second-Generation DNA Sequencing Market Share by Revenue, by Players (2021-2026)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by Prenatal Second-Generation DNA Sequencing Revenue

5.4 Global Prenatal Second-Generation DNA Sequencing Market Concentration Analysis

5.4.1 Global Prenatal Second-Generation DNA Sequencing Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by Prenatal Second-Generation DNA Sequencing Revenue in 2025

5.5 Global Key Players of Prenatal Second-Generation DNA Sequencing Head Offices and Areas Served

5.6 Global Key Players of Prenatal Second-Generation DNA Sequencing, Product and Application

5.7 Global Key Players of Prenatal Second-Generation DNA Sequencing, Date of Entry into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Prenatal Second-Generation DNA Sequencing Revenue by Company (2021-2026)

6.1.2 North America Market Size by Type

6.1.2.1 North America Prenatal Second-Generation DNA Sequencing Market Size by Type (2021-2026)

6.1.2.2 North America Prenatal Second-Generation DNA Sequencing Market Share by Type (2021-2026)

6.1.3 North America Market Size by Application

6.1.3.1 North America Prenatal Second-Generation DNA Sequencing Market Size by Application (2021-2026)

6.1.3.2 North America Prenatal Second-Generation DNA Sequencing Market Share by Application (2021-2026)

6.1.4 North America Prenatal Second-Generation DNA Sequencing Major Customers

6.1.5 North America Market Trends and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Prenatal Second-Generation DNA Sequencing Revenue by Company (2021-2026)

6.2.2 Europe Market Size by Type

6.2.2.1 Europe Prenatal Second-Generation DNA Sequencing Market Size by Type (2021-2026)

6.2.2.2 Europe Prenatal Second-Generation DNA Sequencing Market Share by Type (2021-2026)

6.2.3 Europe Market Size by Application

6.2.3.1 Europe Prenatal Second-Generation DNA Sequencing Market Size by Application (2021-2026)

6.2.3.2 Europe Prenatal Second-Generation DNA Sequencing Market Share by Application (2021-2026)

6.2.4 Europe Prenatal Second-Generation DNA Sequencing Major Customers

6.2.5 Europe Market Trends and Opportunities

6.3 China Market: Players, Segments, Downstream and Major Customers

6.3.1 China Prenatal Second-Generation DNA Sequencing Revenue by Company (2021-2026)

6.3.2 China Market Size by Type

6.3.2.1 China Prenatal Second-Generation DNA Sequencing Market Size by Type (2021-2026)

6.3.2.2 China Prenatal Second-Generation DNA Sequencing Market Share by Type (2021-2026)

6.3.3 China Market Size by Application

6.3.3.1 China Prenatal Second-Generation DNA Sequencing Market Size by Application (2021-2026)

6.3.3.2 China Prenatal Second-Generation DNA Sequencing Market Share by Application (2021-2026)

6.3.4 China Prenatal Second-Generation DNA Sequencing Major Customers

6.3.5 China Market Trends and Opportunities

6.4 Japan Market: Players, Segments, Downstream and Major Customers

6.4.1 Japan Prenatal Second-Generation DNA Sequencing Revenue by Company (2021-2026)

6.4.2 Japan Market Size by Type

6.4.2.1 Japan Prenatal Second-Generation DNA Sequencing Market Size by Type (2021-2026)

6.4.2.2 Japan Prenatal Second-Generation DNA Sequencing Market Share by Type (2021-2026)

6.4.3 Japan Market Size by Application

6.4.3.1 Japan Prenatal Second-Generation DNA Sequencing Market Size by Application (2021-2026)

6.4.3.2 Japan Prenatal Second-Generation DNA Sequencing Market Share by Application (2021-2026)

6.4.4 Japan Prenatal Second-Generation DNA Sequencing Major Customers

6.4.5 Japan Market Trends and Opportunities

6.5 Southeast Asia Market: Players, Segments, Downstream and Major Customers

6.5.1 Southeast Asia Prenatal Second-Generation DNA Sequencing Revenue by Company (2021-2026)

6.5.2 Southeast Asia Market Size by Type

6.5.2.1 Southeast Asia Prenatal Second-Generation DNA Sequencing Market Size by Type (2021-2026)

6.5.2.2 Southeast Asia Prenatal Second-Generation DNA Sequencing Market Share by Type (2021-2026)

6.5.3 Southeast Asia Market Size by Application

6.5.3.1 Southeast Asia Prenatal Second-Generation DNA Sequencing Market Size by Application (2021-2026)

6.5.3.2 Southeast Asia Prenatal Second-Generation DNA Sequencing Market Share by Application (2021-2026)

6.5.4 Southeast Asia Prenatal Second-Generation DNA Sequencing Major Customers

6.5.5 Southeast Asia Market Trends and Opportunities

6.6 India Market: Players, Segments, Downstream and Major Customers

6.6.1 India Prenatal Second-Generation DNA Sequencing Revenue by Company (2021-2026)

6.6.2 India Market Size by Type

6.6.2.1 India Prenatal Second-Generation DNA Sequencing Market Size by Type (2021-2026)

6.6.2.2 India Prenatal Second-Generation DNA Sequencing Market Share by Type (2021-2026)

6.6.3 India Market Size by Application

6.6.3.1 India Prenatal Second-Generation DNA Sequencing Market Size by Application (2021-2026)

6.6.3.2 India Prenatal Second-Generation DNA Sequencing Market Share by Application (2021-2026)

6.6.4 India Prenatal Second-Generation DNA Sequencing Major Customers

6.6.5 India Market Trends and Opportunities

7 Key Player Profiles

7.1 Natera

7.1.1 Natera Company Details

7.1.2 Natera Business Overview

7.1.3 Natera Prenatal Second-Generation DNA Sequencing Introduction

7.1.4 Natera Revenue in Prenatal Second-Generation DNA Sequencing Business (2021-2026)

7.1.5 Natera Recent Development

7.2 Labcorp

7.2.1 Labcorp Company Details

7.2.2 Labcorp Business Overview

7.2.3 Labcorp Prenatal Second-Generation DNA Sequencing Introduction

7.2.4 Labcorp Revenue in Prenatal Second-Generation DNA Sequencing Business (2021-2026)

7.2.5 Labcorp Recent Development

7.3 Quest Diagnostics

7.3.1 Quest Diagnostics Company Details

7.3.2 Quest Diagnostics Business Overview

7.3.3 Quest Diagnostics Prenatal Second-Generation DNA Sequencing Introduction

7.3.4 Quest Diagnostics Revenue in Prenatal Second-Generation DNA Sequencing Business (2021-2026)

7.3.5 Quest Diagnostics Recent Development

7.4 MedGenome

7.4.1 MedGenome Company Details

7.4.2 MedGenome Business Overview

7.4.3 MedGenome Prenatal Second-Generation DNA Sequencing Introduction

7.4.4 MedGenome Revenue in Prenatal Second-Generation DNA Sequencing Business (2021-2026)

7.4.5 MedGenome Recent Development

7.5 Mayo Clinic Laboratories

7.5.1 Mayo Clinic Laboratories Company Details

7.5.2 Mayo Clinic Laboratories Business Overview

7.5.3 Mayo Clinic Laboratories Prenatal Second-Generation DNA Sequencing Introduction

7.5.4 Mayo Clinic Laboratories Revenue in Prenatal Second-Generation DNA Sequencing Business (2021-2026)

7.5.5 Mayo Clinic Laboratories Recent Development

7.6 GeneDx

7.6.1 GeneDx Company Details

7.6.2 GeneDx Business Overview

7.6.3 GeneDx Prenatal Second-Generation DNA Sequencing Introduction

7.6.4 GeneDx Revenue in Prenatal Second-Generation DNA Sequencing Business (2021-2026)

7.6.5 GeneDx Recent Development

7.7 PreventionGenetics

7.7.1 PreventionGenetics Company Details

7.7.2 PreventionGenetics Business Overview

7.7.3 PreventionGenetics Prenatal Second-Generation DNA Sequencing Introduction

7.7.4 PreventionGenetics Revenue in Prenatal Second-Generation DNA Sequencing Business (2021-2026)

7.7.5 PreventionGenetics Recent Development

7.8 SYNLAB

7.8.1 SYNLAB Company Details

7.8.2 SYNLAB Business Overview

7.8.3 SYNLAB Prenatal Second-Generation DNA Sequencing Introduction

7.8.4 SYNLAB Revenue in Prenatal Second-Generation DNA Sequencing Business (2021-2026)

7.8.5 SYNLAB Recent Development

7.9 Myriad Genetics

7.9.1 Myriad Genetics Company Details

7.9.2 Myriad Genetics Business Overview

7.9.3 Myriad Genetics Prenatal Second-Generation DNA Sequencing Introduction

7.9.4 Myriad Genetics Revenue in Prenatal Second-Generation DNA Sequencing Business (2021-2026)

7.9.5 Myriad Genetics Recent Development

7.10 GGA

7.10.1 GGA Company Details

7.10.2 GGA Business Overview

7.10.3 GGA Prenatal Second-Generation DNA Sequencing Introduction

7.10.4 GGA Revenue in Prenatal Second-Generation DNA Sequencing Business (2021-2026)

7.10.5 GGA Recent Development

7.11 Fulgent Genetics

7.11.1 Fulgent Genetics Company Details

7.11.2 Fulgent Genetics Business Overview

7.11.3 Fulgent Genetics Prenatal Second-Generation DNA Sequencing Introduction

7.11.4 Fulgent Genetics Revenue in Prenatal Second-Generation DNA Sequencing Business (2021-2026)

7.11.5 Fulgent Genetics Recent Development

7.12 Rainbow Genomics

7.12.1 Rainbow Genomics Company Details

7.12.2 Rainbow Genomics Business Overview

7.12.3 Rainbow Genomics Prenatal Second-Generation DNA Sequencing Introduction

7.12.4 Rainbow Genomics Revenue in Prenatal Second-Generation DNA Sequencing Business (2021-2026)

7.12.5 Rainbow Genomics Recent Development

7.13 BillionToOne

7.13.1 BillionToOne Company Details

7.13.2 BillionToOne Business Overview

7.13.3 BillionToOne Prenatal Second-Generation DNA Sequencing Introduction

7.13.4 BillionToOne Revenue in Prenatal Second-Generation DNA Sequencing Business (2021-2026)

7.13.5 BillionToOne Recent Development

7.14 BGI Genomics

7.14.1 BGI Genomics Company Details

7.14.2 BGI Genomics Business Overview

7.14.3 BGI Genomics Prenatal Second-Generation DNA Sequencing Introduction

7.14.4 BGI Genomics Revenue in Prenatal Second-Generation DNA Sequencing Business (2021-2026)

7.14.5 BGI Genomics Recent Development

7.15 Berry Genomics

7.15.1 Berry Genomics Company Details

7.15.2 Berry Genomics Business Overview

7.15.3 Berry Genomics Prenatal Second-Generation DNA Sequencing Introduction

7.15.4 Berry Genomics Revenue in Prenatal Second-Generation DNA Sequencing Business (2021-2026)

7.15.5 Berry Genomics Recent Development

7.16 Annaroad

7.16.1 Annaroad Company Details

7.16.2 Annaroad Business Overview

7.16.3 Annaroad Prenatal Second-Generation DNA Sequencing Introduction

7.16.4 Annaroad Revenue in Prenatal Second-Generation DNA Sequencing Business (2021-2026)

7.16.5 Annaroad Recent Development

7.17 Weihansi Biomedical Technology

7.17.1 Weihansi Biomedical Technology Company Details

7.17.2 Weihansi Biomedical Technology Business Overview

7.17.3 Weihansi Biomedical Technology Prenatal Second-Generation DNA Sequencing Introduction

7.17.4 Weihansi Biomedical Technology Revenue in Prenatal Second-Generation DNA Sequencing Business (2021-2026)

7.17.5 Weihansi Biomedical Technology Recent Development

8 Prenatal Second-Generation DNA Sequencing Market Dynamics

8.1 Prenatal Second-Generation DNA Sequencing Industry Trends

8.2 Prenatal Second-Generation DNA Sequencing Market Drivers

8.3 Prenatal Second-Generation DNA Sequencing Market Challenges

8.4 Prenatal Second-Generation DNA Sequencing Market Restraints

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Prenatal Second-Generation DNA Sequencing Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Global Prenatal Second-Generation DNA Sequencing Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 3. Global Market Prenatal Second-Generation DNA Sequencing Market Size (US$ Million) by Region:2021 vs 2025 vs 2032

Table 4. Global Prenatal Second-Generation DNA Sequencing Revenue (US$ Million) Market Share by Region (2021-2026)

Table 5. Global Prenatal Second-Generation DNA Sequencing Revenue Share by Region (2021-2026)

Table 6. Global Prenatal Second-Generation DNA Sequencing Revenue (US$ Million) Forecast by Region (2027-2032)

Table 7. Global Prenatal Second-Generation DNA Sequencing Revenue Share Forecast by Region (2027-2032)

Table 8. Global Prenatal Second-Generation DNA Sequencing Market Size by Type (2021-2026) & (US$ Million)

Table 9. Global Prenatal Second-Generation DNA Sequencing Market Share by Revenue, by Type (2021-2026)

Table 10. Global Prenatal Second-Generation DNA Sequencing Forecasted Market Size by Type (2027-2032) & (US$ Million)

Table 11. Global Prenatal Second-Generation DNA Sequencing Market Share by Revenue, by Type (2027-2032)

Table 12. Representative Players of Each Type

Table 13. Global Prenatal Second-Generation DNA Sequencing Market Size by Application (2021-2026) & (US$ Million)

Table 14. Global Prenatal Second-Generation DNA Sequencing Market Share by Revenue, by Application (2021-2026)

Table 15. Global Prenatal Second-Generation DNA Sequencing Forecasted Market Size by Application (2027-2032) & (US$ Million)

Table 16. Global Prenatal Second-Generation DNA Sequencing Market Share by Revenue, by Application (2027-2032)

Table 17. New Sources of Growth in Prenatal Second-Generation DNA Sequencing Applications

Table 18. Global Prenatal Second-Generation DNA Sequencing Revenue by Players (2021-2026) & (US$ Million)

Table 19. Global Prenatal Second-Generation DNA Sequencing Market Share by Players (2021-2026)

Table 20. Global Top Prenatal Second-Generation DNA Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prenatal Second-Generation DNA Sequencing as of 2025)

Table 21. Ranking of Global Top Prenatal Second-Generation DNA Sequencing Companies by Revenue (US$ Million) in 2025

Table 22. Global 5 Largest Players Market Share by Prenatal Second-Generation DNA Sequencing Revenue (CR5 and HHI) & (2021-2026)

Table 23. Global Key Players of Prenatal Second-Generation DNA Sequencing, Headquarters and Area Served

Table 24. Global Key Players of Prenatal Second-Generation DNA Sequencing, Product and Application

Table 25. Global Key Players of Prenatal Second-Generation DNA Sequencing, Date of Entry into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. North America Prenatal Second-Generation DNA Sequencing Revenue by Company (2021-2026) & (US$ Million)

Table 28. North America Prenatal Second-Generation DNA Sequencing Market Share by Revenue, by Company (2021-2026)

Table 29. North America Prenatal Second-Generation DNA Sequencing Market Size by Type (2021-2026) & (US$ Million)

Table 30. North America Prenatal Second-Generation DNA Sequencing Market Size by Application (2021-2026) & (US$ Million)

Table 31. Europe Prenatal Second-Generation DNA Sequencing Revenue by Company (2021-2026) & (US$ Million)

Table 32. Europe Prenatal Second-Generation DNA Sequencing Market Share by Revenue, by Company (2021-2026)

Table 33. Europe Prenatal Second-Generation DNA Sequencing Market Size by Type (2021-2026) & (US$ Million)

Table 34. Europe Prenatal Second-Generation DNA Sequencing Market Size by Application (2021-2026) & (US$ Million)

Table 35. China Prenatal Second-Generation DNA Sequencing Revenue by Company (2021-2026) & (US$ Million)

Table 36. China Prenatal Second-Generation DNA Sequencing Market Share by Revenue, by Company (2021-2026)

Table 37. China Prenatal Second-Generation DNA Sequencing Market Size by Type (2021-2026) & (US$ Million)

Table 38. China Prenatal Second-Generation DNA Sequencing Market Size by Application (2021-2026) & (US$ Million)

Table 39. Japan Prenatal Second-Generation DNA Sequencing Revenue by Company (2021-2026) & (US$ Million)

Table 40. Japan Prenatal Second-Generation DNA Sequencing Market Share by Revenue, by Company (2021-2026)

Table 41. Japan Prenatal Second-Generation DNA Sequencing Market Size by Type (2021-2026) & (US$ Million)

Table 42. Japan Prenatal Second-Generation DNA Sequencing Market Size by Application (2021-2026) & (US$ Million)

Table 43. Southeast Asia Prenatal Second-Generation DNA Sequencing Revenue by Company (2021-2026) & (US$ Million)

Table 44. Southeast Asia Prenatal Second-Generation DNA Sequencing Market Share by Revenue, by Company (2021-2026)

Table 45. Southeast Asia Prenatal Second-Generation DNA Sequencing Market Size by Type (2021-2026) & (US$ Million)

Table 46. Southeast Asia Prenatal Second-Generation DNA Sequencing Market Size by Application (2021-2026) & (US$ Million)

Table 47. India Prenatal Second-Generation DNA Sequencing Revenue by Company (2021-2026) & (US$ Million)

Table 48. India Prenatal Second-Generation DNA Sequencing Market Share by Revenue, by Company (2021-2026)

Table 49. India Prenatal Second-Generation DNA Sequencing Market Size by Type (2021-2026) & (US$ Million)

Table 50. India Prenatal Second-Generation DNA Sequencing Market Size by Application (2021-2026) & (US$ Million)

Table 51. Natera Company Details

Table 52. Natera Business Overview

Table 53. Natera Prenatal Second-Generation DNA Sequencing Product

Table 54. Natera Revenue in Prenatal Second-Generation DNA Sequencing Business (2021-2026) & (US$ Million)

Table 55. Natera Recent Development

Table 56. Labcorp Company Details

Table 57. Labcorp Business Overview

Table 58. Labcorp Prenatal Second-Generation DNA Sequencing Product

Table 59. Labcorp Revenue in Prenatal Second-Generation DNA Sequencing Business (2021-2026) & (US$ Million)

Table 60. Labcorp Recent Development

Table 61. Quest Diagnostics Company Details

Table 62. Quest Diagnostics Business Overview

Table 63. Quest Diagnostics Prenatal Second-Generation DNA Sequencing Product

Table 64. Quest Diagnostics Revenue in Prenatal Second-Generation DNA Sequencing Business (2021-2026) & (US$ Million)

Table 65. Quest Diagnostics Recent Development

Table 66. MedGenome Company Details

Table 67. MedGenome Business Overview

Table 68. MedGenome Prenatal Second-Generation DNA Sequencing Product

Table 69. MedGenome Revenue in Prenatal Second-Generation DNA Sequencing Business (2021-2026) & (US$ Million)

Table 70. MedGenome Recent Development

Table 71. Mayo Clinic Laboratories Company Details

Table 72. Mayo Clinic Laboratories Business Overview

Table 73. Mayo Clinic Laboratories Prenatal Second-Generation DNA Sequencing Product

Table 74. Mayo Clinic Laboratories Revenue in Prenatal Second-Generation DNA Sequencing Business (2021-2026) & (US$ Million)

Table 75. Mayo Clinic Laboratories Recent Development

Table 76. GeneDx Company Details

Table 77. GeneDx Business Overview

Table 78. GeneDx Prenatal Second-Generation DNA Sequencing Product

Table 79. GeneDx Revenue in Prenatal Second-Generation DNA Sequencing Business (2021-2026) & (US$ Million)

Table 80. GeneDx Recent Development

Table 81. PreventionGenetics Company Details

Table 82. PreventionGenetics Business Overview

Table 83. PreventionGenetics Prenatal Second-Generation DNA Sequencing Product

Table 84. PreventionGenetics Revenue in Prenatal Second-Generation DNA Sequencing Business (2021-2026) & (US$ Million)

Table 85. PreventionGenetics Recent Development

Table 86. SYNLAB Company Details

Table 87. SYNLAB Business Overview

Table 88. SYNLAB Prenatal Second-Generation DNA Sequencing Product

Table 89. SYNLAB Revenue in Prenatal Second-Generation DNA Sequencing Business (2021-2026) & (US$ Million)

Table 90. SYNLAB Recent Development

Table 91. Myriad Genetics Company Details

Table 92. Myriad Genetics Business Overview

Table 93. Myriad Genetics Prenatal Second-Generation DNA Sequencing Product

Table 94. Myriad Genetics Revenue in Prenatal Second-Generation DNA Sequencing Business (2021-2026) & (US$ Million)

Table 95. Myriad Genetics Recent Development

Table 96. GGA Company Details

Table 97. GGA Business Overview

Table 98. GGA Prenatal Second-Generation DNA Sequencing Product

Table 99. GGA Revenue in Prenatal Second-Generation DNA Sequencing Business (2021-2026) & (US$ Million)

Table 100. GGA Recent Development

Table 101. Fulgent Genetics Company Details

Table 102. Fulgent Genetics Business Overview

Table 103. Fulgent Genetics Prenatal Second-Generation DNA Sequencing Product

Table 104. Fulgent Genetics Revenue in Prenatal Second-Generation DNA Sequencing Business (2021-2026) & (US$ Million)

Table 105. Fulgent Genetics Recent Development

Table 106. Rainbow Genomics Company Details

Table 107. Rainbow Genomics Business Overview

Table 108. Rainbow Genomics Prenatal Second-Generation DNA Sequencing Product

Table 109. Rainbow Genomics Revenue in Prenatal Second-Generation DNA Sequencing Business (2021-2026) & (US$ Million)

Table 110. Rainbow Genomics Recent Development

Table 111. BillionToOne Company Details

Table 112. BillionToOne Business Overview

Table 113. BillionToOne Prenatal Second-Generation DNA Sequencing Product

Table 114. BillionToOne Revenue in Prenatal Second-Generation DNA Sequencing Business (2021-2026) & (US$ Million)

Table 115. BillionToOne Recent Development

Table 116. BGI Genomics Company Details

Table 117. BGI Genomics Business Overview

Table 118. BGI Genomics Prenatal Second-Generation DNA Sequencing Product

Table 119. BGI Genomics Revenue in Prenatal Second-Generation DNA Sequencing Business (2021-2026) & (US$ Million)

Table 120. BGI Genomics Recent Development

Table 121. Berry Genomics Company Details

Table 122. Berry Genomics Business Overview

Table 123. Berry Genomics Prenatal Second-Generation DNA Sequencing Product

Table 124. Berry Genomics Revenue in Prenatal Second-Generation DNA Sequencing Business (2021-2026) & (US$ Million)

Table 125. Berry Genomics Recent Development

Table 126. Annaroad Company Details

Table 127. Annaroad Business Overview

Table 128. Annaroad Prenatal Second-Generation DNA Sequencing Product

Table 129. Annaroad Revenue in Prenatal Second-Generation DNA Sequencing Business (2021-2026) & (US$ Million)

Table 130. Annaroad Recent Development

Table 131. Weihansi Biomedical Technology Company Details

Table 132. Weihansi Biomedical Technology Business Overview

Table 133. Weihansi Biomedical Technology Prenatal Second-Generation DNA Sequencing Product

Table 134. Weihansi Biomedical Technology Revenue in Prenatal Second-Generation DNA Sequencing Business (2021-2026) & (US$ Million)

Table 135. Weihansi Biomedical Technology Recent Development

Table 136. Prenatal Second-Generation DNA Sequencing Market Trends

Table 137. Prenatal Second-Generation DNA Sequencing Market Drivers

Table 138. Prenatal Second-Generation DNA Sequencing Market Challenges

Table 139. Prenatal Second-Generation DNA Sequencing Market Restraints

Table 140. Research Programs/Design for This Report

Table 141. Key Data Information from Secondary Sources

Table 142. Key Data Information from Primary Sources

List of Figures

Figure 1. Prenatal Second-Generation DNA Sequencing Product Picture

Figure 2. Global Prenatal Second-Generation DNA Sequencing Market Share by Type: 2025 vs 2032

Figure 3. Targeted Panels Features

Figure 4. Exome Sequencing Features

Figure 5. Others Features

Figure 6. Global Prenatal Second-Generation DNA Sequencing Market Share by Application: 2025 vs 2032

Figure 7. Public Hospitals

Figure 8. Private Hospitals

Figure 9. Prenatal Second-Generation DNA Sequencing Report Years Considered

Figure 10. Global Prenatal Second-Generation DNA Sequencing Market Size (US$ Million), Year-over-Year: 2021-2032

Figure 11. Global Prenatal Second-Generation DNA Sequencing Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 12. Global Prenatal Second-Generation DNA Sequencing Market Share by Revenue, by Region: 2021 vs 2025

Figure 13. North America Prenatal Second-Generation DNA Sequencing Revenue (US$ Million) Growth Rate (2021-2032)

Figure 14. Europe Prenatal Second-Generation DNA Sequencing Revenue (US$ Million) Growth Rate (2021-2032)

Figure 15. China Prenatal Second-Generation DNA Sequencing Revenue (US$ Million) Growth Rate (2021-2032)

Figure 16. Japan Prenatal Second-Generation DNA Sequencing Revenue (US$ Million) Growth Rate (2021-2032)

Figure 17. Southeast Asia Prenatal Second-Generation DNA Sequencing Revenue (US$ Million) Growth Rate (2021-2032)

Figure 18. India Prenatal Second-Generation DNA Sequencing Revenue (US$ Million) Growth Rate (2021-2032)

Figure 19. South America Prenatal Second-Generation DNA Sequencing Revenue (US$ Million) Growth Rate (2021-2032)

Figure 20. Middle East Prenatal Second-Generation DNA Sequencing Revenue (US$ Million) Growth Rate (2021-2032)

Figure 21. Global Prenatal Second-Generation DNA Sequencing Market Share by Players in 2025

Figure 22. Global Top Prenatal Second-Generation DNA Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prenatal Second-Generation DNA Sequencing as of 2025)

Figure 23. The Top 10 and 5 Players Market Share by Prenatal Second-Generation DNA Sequencing Revenue in 2025

Figure 24. North America Prenatal Second-Generation DNA Sequencing Market Share by Type (2021-2026)

Figure 25. North America Prenatal Second-Generation DNA Sequencing Market Share by Application (2021-2026)

Figure 26. Europe Prenatal Second-Generation DNA Sequencing Market Share by Type (2021-2026)

Figure 27. Europe Prenatal Second-Generation DNA Sequencing Market Share by Application (2021-2026)

Figure 28. China Prenatal Second-Generation DNA Sequencing Market Share by Type (2021-2026)

Figure 29. China Prenatal Second-Generation DNA Sequencing Market Share by Application (2021-2026)

Figure 30. Japan Prenatal Second-Generation DNA Sequencing Market Share by Type (2021-2026)

Figure 31. Japan Prenatal Second-Generation DNA Sequencing Market Share by Application (2021-2026)

Figure 32. Southeast Asia Prenatal Second-Generation DNA Sequencing Market Share by Type (2021-2026)

Figure 33. Southeast Asia Prenatal Second-Generation DNA Sequencing Market Share by Application (2021-2026)

Figure 34. India Prenatal Second-Generation DNA Sequencing Market Share by Type (2021-2026)

Figure 35. India Prenatal Second-Generation DNA Sequencing Market Share by Application (2021-2026)

Figure 36. Natera Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2021-2026)

Figure 37. Labcorp Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2021-2026)

Figure 38. Quest Diagnostics Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2021-2026)

Figure 39. MedGenome Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2021-2026)

Figure 40. Mayo Clinic Laboratories Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2021-2026)

Figure 41. GeneDx Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2021-2026)

Figure 42. PreventionGenetics Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2021-2026)

Figure 43. SYNLAB Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2021-2026)

Figure 44. Myriad Genetics Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2021-2026)

Figure 45. GGA Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2021-2026)

Figure 46. Fulgent Genetics Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2021-2026)

Figure 47. Rainbow Genomics Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2021-2026)

Figure 48. BillionToOne Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2021-2026)

Figure 49. BGI Genomics Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2021-2026)

Figure 50. Berry Genomics Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2021-2026)

Figure 51. Annaroad Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2021-2026)

Figure 52. Weihansi Biomedical Technology Revenue Growth Rate in Prenatal Second-Generation DNA Sequencing Business (2021-2026)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

Figure 55. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Prenatal Second-Generation DNA Sequencing in 2032? zhanKai

The global market size of Prenatal Second-Generation DNA Sequencing in 2032 was 1842 Million USD.

Which companies rank high in the global Prenatal Second-Generation DNA Sequencing market? shouQi

What was the global market size of Prenatal Second-Generation DNA Sequencing in 2026? shouQi

Which region is expected to have the highest market share? shouQi

What is the annual compound growth rate of the global Prenatal Second-Generation DNA Sequencing market size from 2026 to 2032? shouQi

Related Reports

Global Prenatal Second-Generation DNA Sequencing Market Research Report 2026
The global Prenatal Second-Generation DNA Sequencing market was valued at US$ 897 million in 2025 and is anticipated to reach US$ 1842 million by 2032, at a CAGR of 10.9% from 2026 to 2032.
Published Date: 2026-03-11
Pages: 130
USD 2900.00
(Single User License)
Global Prenatal Second-Generation DNA Sequencing Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Prenatal Second-Generation DNA Sequencing market is projected to grow from US$ 897 million in 2025 to US$ 1842 million by 2032, at a CAGR of 10.9% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-11
Pages: 151
USD 4900.00
(Single User License)
Prenatal Second-Generation DNA Sequencing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Prenatal Second-Generation DNA Sequencing was estimated to be worth US$ 897 million in 2025 and is projected to reach US$ 1842 million, growing at a CAGR of 10.9% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 121
USD 3950.00
(Single User License)
Global Prenatal Second-Generation DNA Sequencing Market Research Report 2025
The global market for Prenatal Second-Generation DNA Sequencing was valued at US$ 1290 million in the year 2024 and is projected to reach a revised size of US$ 2458 million by 2031, growing at a CAGR of 9.7% during the forecast period.
Published Date: 2025-04-13
Pages: 108
USD 2900.00
(Single User License)
Global Prenatal Second-Generation DNA Sequencing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Prenatal Second-Generation DNA Sequencing market size was US$ 1290 million in 2024 and is forecast to a readjusted size of US$ 2458 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published Date: 2025-04-13
Pages: 117
USD 4250.00
(Single User License)
Prenatal Second-Generation DNA Sequencing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Prenatal Second-Generation DNA Sequencing was estimated to be worth US$ 1290 million in 2024 and is forecast to a readjusted size of US$ 2458 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published Date: 2025-04-13
Pages: 160
USD 3950.00
(Single User License)
Global Prenatal Second-Generation DNA Sequencing Market Insights, Forecast to 2031
The global Prenatal Second-Generation DNA Sequencing market is projected to grow from US$ 1414 million in 2025 to US$ 2458 million by 2031, at a Compound Annual Growth Rate (CAGR) of 9.7% during the forecast period.
Published Date: 2025-04-13
Pages: 166
USD 4900.00
(Single User License)

Global Prenatal Second-Generation DNA Sequencing Market Research Report 2026
The global Prenatal Second-Generation DNA Sequencing market was valued at US$ 897 million in 2025 and is anticipated to reach US$ 1842 million by 2032, at a CAGR of 10.9% from 2026 to 2032.
Published: 2026-03-11
Pages: 130
USD 2900.00 (Single User License)
Global Prenatal Second-Generation DNA Sequencing Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Prenatal Second-Generation DNA Sequencing market is projected to grow from US$ 897 million in 2025 to US$ 1842 million by 2032, at a CAGR of 10.9% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-11
Pages: 151
USD 4900.00 (Single User License)
Prenatal Second-Generation DNA Sequencing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Prenatal Second-Generation DNA Sequencing was estimated to be worth US$ 897 million in 2025 and is projected to reach US$ 1842 million, growing at a CAGR of 10.9% from 2026 to 2032.
Published: 2026-03-09
Pages: 121
USD 3950.00 (Single User License)
Global Prenatal Second-Generation DNA Sequencing Market Research Report 2025
The global market for Prenatal Second-Generation DNA Sequencing was valued at US$ 1290 million in the year 2024 and is projected to reach a revised size of US$ 2458 million by 2031, growing at a CAGR of 9.7% during the forecast period.
Published: 2025-04-13
Pages: 108
USD 2900.00 (Single User License)
Global Prenatal Second-Generation DNA Sequencing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Prenatal Second-Generation DNA Sequencing market size was US$ 1290 million in 2024 and is forecast to a readjusted size of US$ 2458 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published: 2025-04-13
Pages: 117
USD 4250.00 (Single User License)
Prenatal Second-Generation DNA Sequencing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Prenatal Second-Generation DNA Sequencing was estimated to be worth US$ 1290 million in 2024 and is forecast to a readjusted size of US$ 2458 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
Published: 2025-04-13
Pages: 160
USD 3950.00 (Single User License)
Global Prenatal Second-Generation DNA Sequencing Market Insights, Forecast to 2031
The global Prenatal Second-Generation DNA Sequencing market is projected to grow from US$ 1414 million in 2025 to US$ 2458 million by 2031, at a Compound Annual Growth Rate (CAGR) of 9.7% during the forecast period.
Published: 2025-04-13
Pages: 166
USD 4900.00 (Single User License)